prohibition partners
prohibition partners · page 5
- Events
International Experts Gather to Shape the Future of Cannabis Legislation at the Inaugural Global Cannabis Regulatory Summit
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
- Data & Analysis
Australia’s Medical Cannabis Market Set to Outgrow Europe’s Biggest Players
According to Prohibition Partners’ new Global Cannabis Report: 5th Edition, launching today, Australia’s medical cannabis revenues are expected to grow from around US$600m in 2024 to more than US$1.2bn by 2028.
- Events
Prohibition Partners and Mary Jane Berlin Announce Launch of International Cannabis Business Day
Prohibition Partners and Mary Jane Berlin are proud to announce a strategic partnership to host the International Cannabis Business Day as part of the Mary Jane Berlin festival on June 19, 2025.
- Data & Analysis
European Medical Cannabis Boom Driven by Telemedicine and Regulatory Reforms
Telemedicine technology is driving rapid expansion of medical cannabis markets across Europe, according to Prohibition Partners’ upcoming Global Cannabis Report: 5th Edition.
- Data & Analysis
German Medical Cannabis Market to Top €420m in 2024 Amid ‘Second Wave of German Cannabis’
Germany’s flourishing medical cannabis market is now forecast to top €420m this year, according to Prohibition Partners’ upcoming German Cannabis Report.
- Events
Business of Cannabis: Berlin 2024 – Uniting Industry Leaders to Shape Germany’s Cannabis Future on 26 November
The Business of Cannabis: Berlin Executive Summit is set to host over 150 top executives, policymakers, and thought leaders at Palisa.de on 26 November, as Germany navigates a crucial phase in its cannabis industry development.
- Cultivation
Germany’s Domestic Cannabis Cultivation Market Poised for Significant Growth as 3 New Licences Issued
Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has now issued the first three new licences for domestic cannabis cultivation, expected to see the amount of product grown in the country at least double this year.
- Data & Analysis
Prohibition Partners Launches New Bespoke Data & Analysis Packages
Prohibition Partners, leading providers of data, intelligence and insights on international cannabis markets, are announcing the launch of their new Bespoke Data & Analysis Packages at Cannabis Europa 2024.
- Policy & Regulation
New Cannabis Regulations in Bundestag: Traffic Rules, Cultivation Restrictions, and Training Programs
Written for Business of Cannabis by Prohibition Partners Senior Analyst Alex Khourdaji In the late evening of 16th May 2024, the Bundestag held its first reading of the first draft law to amend the Consumer Cannabis Act and the Medical Cannabis Act in the Bundestag as well as amendments to the Road Traffic Act.
- Data & Analysis
UK’s Medical Cannabis Boom: Patients, Demand, and Consumption Surge to All-Time Highs – With a Record Number of Private Clinics
The UK is the primary driver of new growth in Europe’s medical cannabis market, with sales of medical cannabis greater than expected due to ‘unusually high’ consumption volumes on a per-patient basis.
- Policy & Regulation
Speedy Amnesty for Cannabis Convictions in Germany
Written for Business of Cannabis by Prohibition Partners Senior Analyst Alex Khourdaji According to a recent request made by the ARD to all federal states in Germany, over 125 people have been released from prison due to the new amnesty rules associated with the recent partial cannabis legalisation in the country.
- Data & Analysis
From Pioneer to Global Supplier: Canada’s Crucial Role in Global Cannabis Expansion
Canada’s landmark Cannabis Act saw it become the first major developed country to legalise and regulate cannabis in 2018.
